Department of Biology, University of Winnipeg, 599 Portage Avenue, Winnipeg, MB R3B 2G3, Canada
Mini Review
Human Monkeypox Episodes are Treated with Antivirals Produced by Antivirals
Author(s): Domenico Douville*
The World Health Organization recently declared human monkeypox virus infection a public health emergency of international concern (PHEIC).
Furthermore, there is little literature on the use of antivirals in monkeypox virus infection. This systematic review compiles all evidence on the
efficacy, safety, and mechanisms of action of various antivirals. All original studies mentioning individual patient data on the use of antivirals in
patients with monkeypox virus infection were reviewed. Tecovirimat is the most commonly used and has proven to be beneficial in a number of
aggravating cases. Its use revealed no major safety concerns. Topical trifluridine was used as an adjuvant treatment option along with Tecovirimat.
BCV and CDV were rarely used, with the latter frequently used due to the Tecovirimat is not available. Treatment discontinuation due to adverse
even.. Read More»
DOI:
10.37421/2576-1420.2022.7.267
Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report